Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 87Lymphoma, Non-Hodgkin 72Lymphoma 63Lymphoma, Follicular 59Lymphoma, Mantle-Cell 58Lymphoma, Large B-Cell, Diffuse 40Hodgkin Disease 32Lymphoma, B-Cell, Marginal Zone 28Recurrence 25Lymphoma, B-Cell 19Leukemia 17Waldenstrom Macroglobulinemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms 11Lymphoma, T-Cell 7Burkitt Lymphoma 7Lymphoma, T-Cell, Peripheral 6Leukemia, Myeloid, Acute 6Leukemia, B-Cell 6Sezary Syndrome 5Mycosis Fungoides 5Multiple Myeloma 5Immune System Diseases 5Myelodysplastic Syndromes 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Extranodal NK-T-Cell 4Lymphatic Diseases 4Immunoblastic Lymphadenopathy 4

Interventions

glucarpidase 2safinamide 1sacubitril and valsartan sodium hydrate drug combination 1ripretinib 1mirabegron 1gamma-Glutamyl Hydrolase 1Sitagliptin Phosphate 1Rituximab 1Methotrexate 1Leucovorin 1Lenalidomide 1Eplerenone 1Duration of Therapy 1Cyclophosphamide 1Cilengitide 1Carboxypeptidases 1Bendamustine Hydrochloride 1Azacitidine 13-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Bendamustine Hydrochloride × Lymphoid × Clear all
NCT01832922 2018-03-30

BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
8 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡